Advanced Lung Cancer Clinical Trials
1 recruiting
Showing 1–10 of 10 trials
Recruiting
Not Applicable
Engage Psychosocial Intervention for Cancer Symptoms
Advanced Breast CancerAdvanced Prostate CancerAdvanced Lung Cancer+2 more
Duke University190 enrolled1 locationNCT06555588
Recruiting
Phase 1
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Metastatic Breast CancerAdvanced Breast CancerMetastatic Lung Cancer+6 more
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)392 enrolled31 locationsNCT06625775
Recruiting
Phase 1Phase 2
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
Advanced Lung Cancer
BioNTech SE594 enrolled45 locationsNCT06892548
Recruiting
Not Applicable
Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients
Advanced Breast CancerEarly Breast CancerAdvanced Lung Cancer+5 more
Ulsan University Hospital414 enrolled5 locationsNCT07405931
Recruiting
Early Phase 1
Inhaled mRNA Tumor-associated Antigen Dry Powder Vaccine in Advanced Lung Cancer and Lung Metastasis of Solid Tumors.
Advanced Lung CancerLung Metastasis
Cancer Institute and Hospital, Chinese Academy of Medical Sciences83 enrolled1 locationNCT06928922
Recruiting
Phase 1
Clinical Study on Chimeric Antigen Receptor T Lymphocyte (CAR-T) Targeting CEA for the Treatment of CEA - Positive Advanced Lung Cancer
Advanced Lung Cancer
Chongqing Precision Biotech Co., Ltd60 enrolled1 locationNCT06945523
Recruiting
Phase 1
A Clinical Trial of CEA Targeting CAR-T for CEA Positive Advanced Lung Cancer
Advanced Lung Cancer
Chongqing Precision Biotech Co., Ltd48 enrolled1 locationNCT06768151
Recruiting
A Real-World Study of Treatment Patterns and Effectiveness in MET Mutation-Positive Advanced Lung Cancer
Advanced Lung Cancer
Hunan Province Tumor Hospital200 enrolled1 locationNCT06183762
Recruiting
Early Phase 1
WTX212A Monotherapy and in Combination With PD -1/PD-L1 Monoclonal Antibody
Advanced Lung Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University20 enrolled1 locationNCT06106152
Recruiting
Differences in Rate of Decline in CT-defined Skeletal Muscle Mass and Physical Performance in Patients With Advanced Non-small Cell Lung Cancer Receiving Chemotherapy and Targeted Therapy/Immunotherapy, Before and After Treatment.
SarcopeniaAdvanced Lung Cancer
Prince of Songkla University240 enrolled1 locationNCT06326086